KL-6, a human MUC1 mucin, is expressed early in premature lung

被引:19
作者
Sun, AP
Ohtsuki, Y [1 ]
Fujita, J
Ishida, T
Yoshinouchi, T
Kohno, N
机构
[1] Kochi Med Sch, Dept Pathol, Nanko Ku, Kochi 7838505, Japan
[2] Kagawa Med Univ, Dept Internal Med, Kagawa, Japan
[3] Nagoya City Univ, Sch Med, Dept Internal Med, Nagoya, Aichi 467, Japan
[4] Hiroshima Univ, Sch Med, Dept Internal Med, Hiroshima, Japan
关键词
KL-6; MUC1; surfactant protein A; premature lung; hyaline membrane; immunohistochemistry;
D O I
10.1016/S0954-6111(03)00124-0
中图分类号
R5 [内科学];
学科分类号
1002 [临床医学]; 100201 [内科学];
摘要
KL-6, one of the MUC1 antigens, is a mucin-like high-molecular-weight glycoprotein, which is strongly expressed on type II pneumocytes. Serum levels of KL-6 have been shown to correlate with activity of interstitial pneumonia (IP). During embryonic development, MUC1 expression coincides with the onset of epithelial sheet and glandular formation. To investigate the potential role of KL-6 in lung morphogenesis, we examined KL-6 expression by immunohistochemistry on autopsied lung tissue specimens of 35 neonates and infants with gestational age from 23 to 40 weeks. Hyaline membranes (HMs) were detected in 13 of 35 cases. Simultaneously, antibody against surfactant protein A (SP-A) was employed in the study which is a distinct marker for type II pneumocytes. In all cases studied with gestational age above 23 weeks, staining for KL-6 was strongly positive in alveolar epithelial cells and in HMs found in 13 cases, whereas immunoreaction for PE10 varied depending on gestational age and duration of postnatal survival. Our findings suggest that KL-6 is expressed earlier in premature lung and may act as an important factor contributing to morphogenesis and function of developing lung in early gestation. (C) 2003 Elsevier Ltd. All rights reserved.
引用
收藏
页码:964 / 969
页数:6
相关论文
共 29 条
[1]
OXYGEN MODULATES THE DIFFERENTIATION OF HUMAN FETAL LUNG INVITRO AND ITS RESPONSIVENESS TO CAMP [J].
ACARREGUI, MJ ;
SNYDER, JM ;
MENDELSON, CR .
AMERICAN JOURNAL OF PHYSIOLOGY, 1993, 264 (05) :L465-L474
[2]
Cancer-associated MUC1 mucin inhibits human T-cell proliferation, which is reversible by IL-2 [J].
Agrawal, B ;
Krantz, MJ ;
Reddish, MA ;
Longenecker, BM .
NATURE MEDICINE, 1998, 4 (01) :43-49
[3]
MUC-1 expression as a predictor of the curative endoscopic treatment of submucosally invasive colorectal carcinoma [J].
Aoki, R ;
Tanaka, S ;
Haruma, K ;
Yoshihara, M ;
Sumii, K ;
Kajiyama, G ;
Shimamoto, F ;
Kohno, N .
DISEASES OF THE COLON & RECTUM, 1998, 41 (10) :1262-1272
[4]
BRAGA VMM, 1992, DEVELOPMENT, V115, P427
[5]
CHAMBERS JA, 1994, J CELL SCI, V107, P413
[6]
Mucin expression in mucinous carcinoma and other invasive carcinomas of the breast [J].
Chu, JS ;
Chang, KJ .
CANCER LETTERS, 1999, 142 (01) :121-127
[7]
DERCOLE AJ, 1987, J DEV PHYSIOL, V9, P481
[8]
Control of pseudohyphae formation in Saccharomyces cerevisiae [J].
Gancedo, JM .
FEMS MICROBIOLOGY REVIEWS, 2001, 25 (01) :107-123
[9]
Guddo F, 1998, ANTICANCER RES, V18, P1915
[10]
MONITORING OF SERUM KL-6 ANTIGEN IN A PATIENT WITH RADIATION PNEUMONIA [J].
HAMADA, H ;
KOHNO, N ;
AKIYAMA, M ;
HIWADA, K .
CHEST, 1992, 101 (03) :858-860